Haemodynamic effects of carbetocin given as i.v. bolus or infusion on women undergoing caesarean delivery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000715

Enrollment

Registered

2013-04-04

Start date

2012-11-14

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : After the delivery of the baby and cord clamping, 100? of carbetocin diluted in 50 ml of normal saline is given for a time period of 5 min by using a infusion pump in the infusion group and sam

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Healthy term parturients (37-41 weeks) with American Society of Anesthesiology Physical Status I and II, who were scheduled to undergo elective cesarean delivery under spinal anesthesia and to receive carbetocin.

Exclusion criteria

Exclusion criteria: Women with preeclampsia, placenta previa, diabetes mellitus or hypertension which conditions could lead to cardiovascular instability

Design outcomes

Primary

Measure	Time frame
Mean blood pressure;Heart rate	—

Secondary

Measure	Time frame
Total peripheral resistance	—

Countries

Korea, Republic of

Contacts

Public ContactKyoungok Kim

Dongguk University Ilsan Hospital

Outcome results